Einstein/Montefiore Department of Medicine

In The Media

The Washington Post interviews Nir Barzilai, M.D., about Donald Trump’s health, human aging, and questions about the factors affecting longevity and healthspan. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein.

(Wednesday, January 18, 2017)

Dr. Barzilai's Profile
 
 

The Washington Post interviews Nir Barzilai, M.D., about Donald Trump’s health, human aging, and questions about the factors affecting longevity and healthspan. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein.

(Wednesday, January 18, 2017)

Dr. Barzilai's Profile
 
 

Reuters interviews Joe Verghese, M.B.B.S., about his research that determined a method of predicting the risk of falling for healthy, older adults. Dr. Verghese is professor and director of the division of cognitive & motor aging in the Saul R. Korey Department of Neurology at Einstein and director of the Montefiore Einstein Center for the Aging Brain.

(Monday, December 12, 2016)

Dr. Verghese's Profile
 
 

New York Times interviews Ana Maria Cuervo, M.D., Ph.D., about the scientist awarded the Nobel Prize for his discoveries on how cells recycle, known as autophagy. Dr. Cuervo is a leader in this field of research, focusing on chaperone-mediated autophagy. Dr. Cuervo is professor of developmental and molecular biology, of anatomy and structural biology, and of medicine, co-director of the Institute for Aging Research, and holds the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Einstein.

(Wednesday, October 05, 2016)

Dr. Cuervo's Profile
 
 

U.S. News & World Report interviews Ana Maria Cuervo, M.D., Ph.D., and Nir Barzilai, M.D., about their aging research.  Drs. Cuervo and Barzilai are co-directors of Einstein’s Institute for Aging Research.

(Tuesday, August 09, 2016)

Dr. Cuervo's Profile | Dr. Barzilai's Profile
 
 

Scientific American interviews Ana Maria Cuervo, M.D., Ph.D., about her research connecting defective proteins, neurodegenerative diseases and a cellular cleaning process. 

(Monday, August 01, 2016)

Dr. Cuervo's Profile
 
 

Scientific American interviews Ana Maria Cuervo, M.D., Ph.D., about her research connecting defective proteins, neurodegenerative diseases and a cellular cleaning process. 

(Monday, August 01, 2016)

Dr. Cuervo's Profile
 
 

The Washington Post interviews Snehal Patel, M.D., about his study that found eliminating a blood test could safely increase the number of donor hearts for transplants. Dr. Patel is assistant professor of medicine at Einstein and attending physician at the Montefiore Einstein Center for Heart and Vascular Care.

(Thursday, June 23, 2016)

Dr. Patel's Profile
 
 

Reuters interviews Michal Melamed, M.D., about her research that found many young, obese adults are unaware they are at risk for kidney disease. Dr. Melamed is associate professor of medicine and of epidemiology & population health at Einstein and attending physician, nephrology at Montefiore Health System.

(Friday, June 03, 2016)

Dr. Melamed's Profile
 
 

Los Angeles Times interviews Chinazo Cunningham, M.D., M.S., about buprenorphine, a drug used to treat opioid addiction, for an article on Prince’s death. Dr. Cunningham is associate chief of general internal medicine in the department of medicine at Einstein and Montefiore.

(Tuesday, May 31, 2016)

Dr. Cunningham's Profile
 
 

Nature interviews John Greally, M.B.B.Ch., Ph.D., about his criticism of a recent New Yorker article on epigenetics. Dr. Greally is professor of genetics, of medicine and of pediatrics and the director of the center for epigenomics at Einstein and attending physician at the Children’s Hospital at Montefiore.

(Tuesday, May 10, 2016)

Dr. Greally's Profile
 
 

The New York Times interviews Chinazo Cunningham, M.D., M.S., about the growing acceptance of harm reduction approaches to drug addiction and treatment. Dr. Cunningham notes that these initiatives, which include needle exchanges and safe injection sites, were once rejected but are now being embraced as opioid and heroin addiction has exploded in white, suburban communities. Dr. Cunningham is professor of medicine and of family and social medicine at Einstein and associate chief of the division of general internal medicine at Einstein and Montefiore.

(Wednesday, April 20, 2016)

Dr. Cunningham's Profile
 
 

The Washington Post quotes Marcus Bachhuber, M.D., M.S., and Chinazo Cunningham, M.D., M.S., about their new study with Joanna Starrels, M.D., M.S., on the surge in overdose deaths from benzodiazepines. Dr. Bachhuber notes that this growing public health problem has largely flown under the radar. Dr. Bachhuber is assistant professor of medicine at Einstein and attending physician, Montefiore; Dr. Cunningham is professor of medicine and of family and social medicine at Einstein and associate chief of the division of general internal medicine at Einstein and Montefiore.

(Tuesday, February 23, 2016)

Dr. Bachhuber's Profile | Dr. Cunningham's Profile | Dr. Starrels' Profile
 
 

The New York Times interviews Dr. Nir Barzilai, M.D., about his upcoming clinical trial to determine if an existing FDA-approved drug can extend health span. Dr. Barzilai and his collaborators at the American Federation for Aging Research will investigate if metformin, a cheap and commonly used medication to treat type 2 diabetes, can delay the onset of several age-related diseases. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein.

(Monday, February 01, 2016)

Dr. Barzilai's Profile
 
 

National Geographic highlights the leadership role Nir Barzilai, M.D., is taking in a clinical trial to determine if a common diabetes drug can delay aging. Dr. Barzilai notes that the goal of the Targeting Aging with Metformin (TAME) study is not to find the “fountain of youth,” but to extend the number of healthy, active years humans can enjoy. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein.

(Thursday, December 03, 2015)

Dr. Barzilai's Profile
 
 
First Page | Previous Page | Page of 15 | Next Page | Last Page
Click here to log in